Literature DB >> 26216127

Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System.

Yun Shen, Yun Lu, Fang Yu, Chuntie Zhu, Hua Wang, Jing Wang1.   

Abstract

The peroxisome proliferator-activated receptor -γ (PPARγ) has been identified in a wide range of cancers, including brain, breast, colon, stomach and lung cancers. It belongs to the thyroid/ steroid hormone receptors superfamily. Binding with their special ligands, PPARγ plays important roles in regulating transcription of their target genes. PPARγ activation suppresses the growth of the tumor cells, implicating the anti-tumor potential of PPARγ ligand. Tumors in the nervous system are among the most devastating cancers. This review highlights key advances in understanding the effects of PPARγ ligands in the treatment of tumors in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26216127     DOI: 10.2174/1574888x10666150728122034

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  1 in total

1.  Cannabis Therapeutics and the Future of Neurology.

Authors:  Ethan B Russo
Journal:  Front Integr Neurosci       Date:  2018-10-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.